Atlas Global Brands Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on Atlas Global Brands's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | 81.3% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Atlas Global Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | 26 | 2 | 0 |
Quality Earnings: AGBI.F has a high level of non-cash earnings.
Growing Profit Margin: AGBI.F became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if AGBI.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: AGBI.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: AGBI.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-13.2%).
Return on Equity
High ROE: AGBI.F's Return on Equity (81.3%) is considered outstanding.